Follow
Ian Tannock
Ian Tannock
Princess Margaret Hospital
Verified email at uhn.ca
Title
Cited by
Cited by
Year
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock, R De Wit, WR Berry, J Horti, A Pluzanska, KN Chi, S Oudard, ...
New England Journal of Medicine 351 (15), 1502-1512, 2004
66702004
Enzalutamide in metastatic prostate cancer before chemotherapy
TM Beer, AJ Armstrong, DE Rathkopf, Y Loriot, CN Sternberg, CS Higano, ...
New England Journal of Medicine 371 (5), 424-433, 2014
28472014
Drug penetration in solid tumours
AI Minchinton, IF Tannock
Nature Reviews Cancer 6 (8), 583-592, 2006
27562006
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis
AJ Templeton, MG McNamara, B Šeruga, FE Vera-Badillo, P Aneja, ...
JNCI: Journal of the National Cancer Institute 106 (6), 2014
22752014
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical …
HI Scher, S Halabi, I Tannock, M Morris, CN Sternberg, MA Carducci, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
21992008
Drug resistance and the solid tumor microenvironment
O Trédan, CM Galmarini, K Patel, IF Tannock
Journal of the National Cancer Institute 99 (19), 1441-1454, 2007
21552007
Acid pH in tumors and its potential for therapeutic exploitation
IF Tannock, D Rotin
Cancer research 49 (16), 4373-4384, 1989
20601989
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
IF Tannock, D Osoba, MR Stockler, DS Ernst, AJ Neville, MJ Moore, ...
Journal of clinical oncology 14 (6), 1756-1764, 1996
19411996
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
C Zimmermann, N Swami, M Krzyzanowska, B Hannon, N Leighl, A Oza, ...
The Lancet 383 (9930), 1721-1730, 2014
15072014
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study
DR Berthold, GR Pond, F Soban, R De Wit, M Eisenberger, IF Tannock
Journal of Clinical Oncology 26 (2), 242-245, 2008
13622008
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
FR Khuri, J Nemunaitis, I Ganly, J Arseneau, IF Tannock, L Romel, ...
Nature medicine 6 (8), 879-885, 2000
13602000
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative …
PJ Loehrer Sr, LH Einhorn, PJ Elson, ED Crawford, P Kuebler, I Tannock, ...
J Clin Oncol 10 (7), 1066-73, 1992
11151992
The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.
IF Tannock
British journal of cancer 22 (2), 258, 1968
9941968
Delivering affordable cancer care in high-income countries
R Sullivan, J Peppercorn, K Sikora, J Zalcberg, NJ Meropol, E Amir, ...
The lancet oncology 12 (10), 933-980, 2011
7422011
Cytokines and their relationship to the symptoms and outcome of cancer
B Seruga, H Zhang, LJ Bernstein, IF Tannock
Nature Reviews Cancer 8 (11), 887-899, 2008
7282008
Repopulation of cancer cells during therapy: an important cause of treatment failure
JJ Kim, IF Tannock
Nature Reviews Cancer 5 (7), 516-525, 2005
7242005
Cognitive function in breast cancer patients receiving adjuvant chemotherapy
CB Brezden, KA Phillips, M Abdolell, T Bunston, IF Tannock
Journal of Clinical Oncology 18 (14), 2695-2701, 2000
6802000
The basic science of oncology
IF Tannock, RP Hill, RG Bristow, L Harrington
McGraw-Hill, 2013
6682013
Bone metastases: pathophysiology and management policy.
OS Nielsen, AJ Munro, IF Tannock
Journal of Clinical Oncology 9 (3), 509-524, 1991
6531991
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisPrognostic Role of PLR in Solid Tumors
AJ Templeton, O Ace, MG McNamara, M Al-Mubarak, FE Vera-Badillo, ...
Cancer epidemiology, biomarkers & prevention 23 (7), 1204-1212, 2014
5832014
The system can't perform the operation now. Try again later.
Articles 1–20